Author: The Brain Tumour Charity

Our wonderful partners at Floor & Wall Ltd took to the fairway as they hosted their first ever charity golf day.

In a new article for Nature Communication, scientists Gelareh Zadeh and Ken Aldape explain that radiation given during childhood cancer treatments causes DNA to rearrange. This rearrangement of DNA can then lead to menigiomas.

Our 2017 Lab Experience is now open! Are you aged 16-17 and interested in lab research? If so, we’d love to hear from you.

We’re thrilled to be partnering with live entertainment company Underbelly, who’ve chosen to support The Brain Tumour Charity at a number of iconic events.

Evolution Coaching has provided The Brain Tumour Charity with exceptional pro bono leadership coaching and professional development training, totalling in excess of £50,000!

Researchers from St. Jude Children’s Research Hospital in the US and the German Cancer Research Centre have discovered faulty genes underlying medulloblastoma brain tumours.

The United States’ Food and Drug Administration (FDA) has approved the use of aminolevulinic acid hydrochloride as an optical imaging agent for use in people affected by high grade gliomas.

Aykroyd & Son’s recently completed the Three Peaks challenge in less than 24 hours, raising £5000!

The most common type of malignant childhood brain cancer has been identified as seven separate conditions each needing a different treatment, new research has revealed.

We are launching a global, patient-led data bank, which will allow patients to unite in sharing their data, helping them to make better informed decisions about their own treatment plans, as well as helping vital research that could bring us closer to finding a cure.

St Andrew’s Fashion Show (FS) has raised over £28,000 for The Brain Tumour Charity in a bid to fund research in to vital treatments to tackle the disease.

Why a decision to cut benefits paid to bereaved parents is not in the interests of affected families.

An energetic team from global financial services technology company Ipreo will soon be taking on the gruelling Tough Mudder in support of The Brain Tumour Charity.

While Theresa May admits division in Westminster, our Chief Executive Sarah Lindsell says we must stand together stronger than ever to defeat brain tumours.

From establishing a new cancer taskforce to ensuring benefits reviews take brain tumour patients into account, read our roundup of key activities from the past few weeks.

Ally Rooney posts an open letter to doctors, nurses, and allied health professionals who care for people with a brain tumour.

Last year, Greater Manchester became the first English region to gain control of health spending. Read our view on the impact this has had on charities.

Diageo chose to support The Brain Tumour Charity following the sudden death of much loved colleague Mark Richardson.

On Sunday 26 March, the House of Lords Select Committee on Charities published a report, ‘Stronger charities for a stronger society’, following an inquiry into issues facing the charity sector in England and Wales.

A team of researchers from Northwestern University, USA have identified a molecule that could be used to inhibit the growth of the most fatal paediatric brain tumour, diffuse pontine intrinsic glioma (DIPG).

Over the last three years, The Brain Tumour Charity has expressed concerns about the assessment criteria used for Personal Independence Payments (PIPs), and their impact on people affected by a brain tumour.

Many news outlets are today reporting concerns from medical research institutions that childhood cancer patients in the UK will miss out on access to clinical trials for new treatments following Brexit.

Dr Thomas Ward, part of the Leeds Institute of Cancer and Pathology research team, is funded by various cancer charities including The Brain Tumour Charity.

Cameron Miller, our Information & Support Services Manager, outlines the growing trend for crowdfunding for treatment funds.